Michael P. Dube

VP, Chief Accounting Officer

VP, Chief Accounting Officer at Intellia Therapeutics, Inc., filing insider transactions between 2026-07-01 and 2026-10-02.

Total Purchases

—

0 transactions

Total Sales

$67K

2 transactions

Companies Traded

2 total filings

Active Since

2026-07-01

Last: 2026-10-02

Companies

Intellia Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-10-02	NTLA	Sale	1,864	$12.43	$23K	65.0K	SEC ↗
2026-07-01	NTLA	Sale	2,641	$16.78	$44K	66.9K	SEC ↗